Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12394/10023
Full metadata record
DC FieldValueLanguage
dc.contributor.authorQuispe, Antonio M.es_ES
dc.contributor.authorSoza, Gabrielaes_ES
dc.contributor.authorRamos Chirinos, Mariaes_ES
dc.contributor.authorQuiroz, Dannyes_ES
dc.contributor.authorPons, Maria J.es_ES
dc.date.accessioned2021-09-01T22:58:32Z-
dc.date.available2021-09-01T22:58:32Z-
dc.date.issued2020-
dc.identifier.citationQuispe, A., Soza, G., Ramos, M., Quiroz, D., Pons, M. (2020). Multidrug resistance bacteremia in neonates and its association with late-onset sepsis and Coagulase-negative Staphylococci. Journal of Infection in Developing Countries, 14(11), 1256-1263. https://doi.org/10.3855/jidc.12568es_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12394/10023-
dc.descriptionIntroduction: This study aimed to assess the association between multidrug resistance (MDR) and late-onset sepsis (LOS) among newborns with bloodstream infection (BSI). Methodology: In this cross-sectional study, we routinely tested every newborn with a presumptive diagnosis of sepsis admitted to the largest reference maternity hospital in Lima, Peru for BSI over an 18-month period. We tested every isolate for MDR by using the disk-diffusion method and assessed its associated factors by using a robust Poisson regression analysis with a particular focus on its association with LOS (vs. early-onset sepsis, EOS). Results: We analyzed a total of 489 subjects, including 340 (69%) newborns with LOS, and estimated an MDR rate of 80% (95% confidence interval, CI: 76%-83%), which was significantly higher (p-value < 0.001) among LOS (85%; 95% CI: 81%-89%) than EOS cases (67%; 95% CI: 59%-75%). The primary isolate was coagulase-negative Staphylococci (CoNS) (60%), which exhibited a limited subset of antibiotic MDR patterns, most of which were characterized by their resistance to cefoxitin, gentamicin, and clindamycin and levofloxacin. Overall, the prevalence of MDR was higher among LOS compared to EOS cases (adjusted prevalence ratio [aPR] = 1.28; 95% CI: 1.14-1.45), and among BSI due to CoNS compared to other bacteria (Apr = 1.10; 95% CI: 1.01-1.20).es_ES
dc.description.abstractJes_ES
dc.formatapplication/pdfes_ES
dc.format.extentp. 1256-1263es_ES
dc.language.isoenges_ES
dc.publisherUniversidad Continentales_ES
dc.relationhttps://jidc.org/index.php/journal/article/view/33296338es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/es_ES
dc.subjectSepsis neonatales_ES
dc.subjectResistencia a fármacoses_ES
dc.subjectAgentes microbianoses_ES
dc.titleMultidrug resistance bacteremia in neonates and its association with late-onset sepsis and Coagulase-negative Staphylococcies_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.licenseAttribution 4.0 International (CC BY 4.0)es_ES
dc.rights.accessRightsAcceso abiertoes_ES
dc.identifier.journalJournal of Infection in Developing Countrieses_ES
dc.identifier.doihttps://doi.org/10.3855/jidc.12568es_ES
dc.subject.ocdehttp://purl.org/pe-repo/ocde/ford#1.02.02es_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersiones_ES
Appears in Collections:Artículos Científicos

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons